SHARE-BASED COMPENSATION (Details 3) - Stock Options [Member] - $ / shares |
3 Months Ended | 12 Months Ended | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2023 |
Dec. 31, 2022 |
Dec. 31, 2021 |
||||||||||||
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||||||||||||
Number of Shares Options Outstanding, Beginning | 7,812,178 | [1] | 5,489,492 | |||||||||||
Exercise Price Outstanding, Beginning | $ 3.70 | [1] | $ 4.23 | |||||||||||
Weighted Average Remaining Contractual Life (Years) | 6 years 3 months 25 days | [2] | 6 years 18 days | 6 years 6 months 21 days | [1] | |||||||||
Weighted-Average Grant Date Fair Value,Beginning | $ 2.23 | [1] | $ 2.27 | |||||||||||
Number of Shares Options Granted | 2,686,337 | |||||||||||||
Exercise Price Granted | $ 2.81 | |||||||||||||
Weighted-Average Grant Date Fair Value,Granted | $ 2.21 | |||||||||||||
Number of Shares Options, Forfeited | (31,523) | (65,634) | ||||||||||||
Exercise Price Forfeited | $ 2.26 | $ 4.50 | ||||||||||||
Weighted-Average Grant Date Fair Value,Forfeited | 1.46 | $ 2.52 | ||||||||||||
Number of Shares Options Expired | (298,017) | |||||||||||||
Exercise Price Expired | $ 5.26 | |||||||||||||
Weighted-Average Grant Date Fair Value,Expired | $ 2.86 | $ 2.82 | ||||||||||||
Number of Shares Options Outstanding, Ending | 7,766,234 | [2] | 7,812,178 | [1] | 5,489,492 | |||||||||
Exercise Price Outstanding, Ending | $ 3.70 | [2] | $ 3.70 | [1] | $ 4.23 | |||||||||
Weighted-Average Grant Date Fair Value,Ending | $ 1.98 | [2] | $ 2.23 | [1] | $ 2.27 | |||||||||
Number of Shares Exercisable at end of period | 4,870,164 | [3] | 4,525,905 | [4] | ||||||||||
Exercise Price Options exercisable at end of period | [4] | $ 4.03 | ||||||||||||
Weighted Average Remaining Contractual Life (Years) exercisable | 4 years 10 months 13 days | [3] | 4 years 10 months 2 days | [4] | ||||||||||
Weighted-average grant date fair value exercisable | [4] | $ 2.13 | ||||||||||||
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|